|
|||||
|
|
QMG and MG‐ADL correlations: Study of eculizumab treatment of myasthenia gravis |
|
| Authors: | James F. Howard MD Jr Miriam Freimer MD Fanny O'Brien PhD Jing Jing Wang MD MS Stephen R. Collins MS John T. Kissel MD |
| Affiliation: | 1. Department of Neurology, University of North Carolina, Chapel Hill, North Carolina, USA;2. Department of Neurology, Ohio State University, Columbus, Ohio, USA;3. Medical Science and Development Operations, Alexion Pharmaceuticals, New Haven, Connecticut, USA;4. Connexion Healthcare, Newtown, Pennsylvania, USA |
| Abstract: | |
| Keywords: | eculizumab myasthenia gravis myasthenia gravis activities of daily living profile patient‐reported outcome physician‐reported outcome quantitative myasthenia gravis |